CSS LLC/IL - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 37 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CSS LLC/IL ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,535,142
+5.2%
8,197,000
+0.5%
0.95%
+11.6%
Q2 2023$13,813,847
+0.1%
8,157,000
+14.8%
0.86%
-6.1%
Q1 2023$13,798,218
+55.6%
7,106,000
+49.7%
0.91%
+81.5%
Q4 2022$8,868,606
+1251.9%
4,747,000
+849.4%
0.50%
+1991.7%
Q1 2022$656,000
-10.5%
500,0000.0%0.02%
-7.7%
Q4 2021$733,000
-97.8%
500,000
-96.3%
0.03%
-98.0%
Q4 2020$33,505,000
+2099.9%
13,674,000
+1760.4%
1.28%
+1683.3%
Q3 2020$1,523,000
-84.0%
735,000
-82.3%
0.07%
-86.7%
Q2 2020$9,531,000
+179.1%
4,144,000
+85.4%
0.54%
+100.7%
Q1 2020$3,415,000
-56.7%
2,235,000
-44.9%
0.27%
-38.4%
Q4 2019$7,893,000
+318.9%
4,054,000
+183.9%
0.44%
+261.2%
Q3 2019$1,884,000
-92.9%
1,428,000
-88.0%
0.12%
-92.1%
Q2 2019$26,504,000
-13.3%
11,928,000
-29.5%
1.52%
-16.9%
Q1 2019$30,560,00016,928,0001.83%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 53,865,000$101,127,2803.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$165,397,6133.42%
Boussard & Gavaudan Investment Management LLP 11,898$21,871,5382.42%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$71,834,2261.71%
WOLVERINE ASSET MANAGEMENT LLC 79,876,000$149,367,3841.55%
CSS LLC/IL 4,747,000$8,868,6060.50%
Opti Capital Management, LP 3,000,000$5,611,9380.48%
Verition Fund Management LLC 16,459,000$30,786,5600.48%
Aequim Alternative Investments LP 5,000,000$9,352,5000.25%
MIZUHO SECURITIES USA LLC 1,097,000$2,047,6160.19%
View complete list of SAREPTA THERAPEUTICS INC shareholders